Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G de Groot

Showing results (441-450 of 778) with videos related to

Pageof 78
Sort By:
Human Immunology|April 1, 1985
Two different T-cell systems in humans, one of which is probably equivalent to Qa or Tla in miceA van Leeuwen, M J Giphart, G de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinuxT Lisman, N R Bijsterveld, J Adelmeijer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1994
Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditionsW L van Heerde, K S Sakariassen, H C Hemker, et al.
Journal of Pediatric Hematology/Oncology|July 27, 2002
Postvaricella purpura fulminans caused by acquired protein s deficiency resulting from antiprotein s antibodies: search for the epitopesC Heleen van Ommen, Merel van Wijnen, Flip G de Groot, et al.
Biochimica Et Biophysica Acta|December 13, 1982
Arachidonate metabolism in cultured human vascular endothelial cells. Evidence for two prostaglandin synthetic pathways sensitive to acetylsalicylic acidC Willems, P G De Groot, G A Pool, et al.
Blood|June 15, 1991
Antibodies to platelets in patients with anti-phospholipid antibodiesH J Out, P G de Groot, M van Vliet, et al.
Plos One|September 13, 2011
Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacityMartine J Hollestelle, Ka Wai Lai, Marcel van Deuren, et al.
Clinical Case Reports|June 12, 2019
Successful soft and hard tissue augmentation with platelet-rich fibrin in combination with bovine bone space maintainer in a delayed implant placement protocol in the esthetic zone: A case reportJoost E I G Brouwers, Sharon Buis, Rianne Haumann, et al.
Blood|April 15, 1997
Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flowH Lankhof, C Damas, M E Schiphorst, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasmaW L Van Heerde, C P M Reutelingsperger, C Maassen, et al.
Pageof 78

Showing results (441-450 of 778) with videos related to

Sort By:
Pageof 78
Human Immunology|April 1, 1985
Two different T-cell systems in humans, one of which is probably equivalent to Qa or Tla in miceA van Leeuwen, M J Giphart, G de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinuxT Lisman, N R Bijsterveld, J Adelmeijer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1994
Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditionsW L van Heerde, K S Sakariassen, H C Hemker, et al.
Journal of Pediatric Hematology/Oncology|July 27, 2002
Postvaricella purpura fulminans caused by acquired protein s deficiency resulting from antiprotein s antibodies: search for the epitopesC Heleen van Ommen, Merel van Wijnen, Flip G de Groot, et al.
Biochimica Et Biophysica Acta|December 13, 1982
Arachidonate metabolism in cultured human vascular endothelial cells. Evidence for two prostaglandin synthetic pathways sensitive to acetylsalicylic acidC Willems, P G De Groot, G A Pool, et al.
Blood|June 15, 1991
Antibodies to platelets in patients with anti-phospholipid antibodiesH J Out, P G de Groot, M van Vliet, et al.
Plos One|September 13, 2011
Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacityMartine J Hollestelle, Ka Wai Lai, Marcel van Deuren, et al.
Clinical Case Reports|June 12, 2019
Successful soft and hard tissue augmentation with platelet-rich fibrin in combination with bovine bone space maintainer in a delayed implant placement protocol in the esthetic zone: A case reportJoost E I G Brouwers, Sharon Buis, Rianne Haumann, et al.
Blood|April 15, 1997
Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flowH Lankhof, C Damas, M E Schiphorst, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasmaW L Van Heerde, C P M Reutelingsperger, C Maassen, et al.
Pageof 78